Form 8-K - Current report:
SEC Accession No. 0000886163-14-000085
Filing Date
2014-07-17
Accepted
2014-07-17 08:06:13
Documents
3
Period of Report
2014-07-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ligandform8-k_preliminaryf.htm 8-K 26021
2 EXHIBIT ligandpre-announcessecondq.htm EX-99.1 15448
3 ligandlogo06.jpg GRAPHIC 14594
  Complete submission text file 0000886163-14-000085.txt   62893
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 14979293
SIC: 2834 Pharmaceutical Preparations